5.38 - 5.60
4.95 - 8.28
2.3K / 2.4K (Avg.)
-279.00 | -0.02
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-4.22%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
5.30%
Gross profit growth similar to METSB.HE's 5.30%. Walter Schloss would assume both firms track common industry trends.
4125.00%
EBIT growth similar to METSB.HE's 4125.00%. Walter Schloss might infer both firms share similar operational efficiencies.
4125.00%
Operating income growth similar to METSB.HE's 4125.00%. Walter Schloss would assume both share comparable operational structures.
1033.33%
Net income growth comparable to METSB.HE's 1033.33%. Walter Schloss might see both following similar market or cost trajectories.
972.21%
EPS growth similar to METSB.HE's 972.21%. Walter Schloss would assume both have parallel share structures and profit trends.
972.21%
Similar diluted EPS growth to METSB.HE's 972.21%. Walter Schloss might see standard sector or cyclical influences on both firms.
7.56%
Share count expansion well above METSB.HE's 7.56%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
7.56%
Diluted share count expanding well above METSB.HE's 7.56%. Michael Burry would fear significant dilution to existing owners' stakes.
No Data
No Data available this quarter, please select a different quarter.
-214.29%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-372.22%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
-9.55%
Both companies have negative long-term revenue/share growth. Martin Whitman would question if the entire market or product set is shrinking.
-9.55%
Both face negative 5Y revenue/share CAGR. Martin Whitman would suspect macro headwinds or obsolete product offerings across the niche.
-9.55%
Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.
-62.18%
Both show negative 10Y OCF/share CAGR. Martin Whitman would question if the entire market or product set is shrinking or too capital-intensive.
-62.18%
Both show negative mid-term OCF/share growth. Martin Whitman might suspect a challenged environment or large capital demands for both.
-62.18%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
249.37%
Similar net income/share CAGR to METSB.HE's 249.37%. Walter Schloss would see parallel tailwinds or expansions for both firms.
249.37%
5Y net income/share CAGR similar to METSB.HE's 249.37%. Walter Schloss might see both on parallel mid-term trajectories.
249.37%
3Y net income/share CAGR similar to METSB.HE's 249.37%. Walter Schloss would attribute it to shared growth factors or demand patterns.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-2.33%
Both reduce inventory yoy. Martin Whitman suspects a broader move to lean operations or industry slowdown in demand.
-0.65%
Both reduce assets yoy. Martin Whitman suspects a broader sector retraction or post-boom asset trimming cycle.
3.01%
Similar to METSB.HE's 3.01%. Walter Schloss finds parallel capital usage or profit distribution strategies.
-0.53%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.